A novel autoregulatory cytokine is required for the regulation of autoaggressive responses.
Limiting dilution studies indicate that cells with the potential to lyse autologous target cells exist in the peripheral blood of all normal individuals. In contrast to allocytotoxic cells, autocytolytic cells are down-regulated by a second less frequent cell population. When recombinant interleukin 2 is substituted for crude lymphocyte conditioned medium in these limiting dilution experiments, autocytotoxicity develops normally. Under these conditions, however, the autocytotoxic response is not down-regulated. Mixing crude lymphocyte-conditioned medium together with recombinant interleukin 2 restores the regulation of autocytotoxicity normally seen at high responder cell dose. These findings indicate that a second soluble factor present in the conditioned medium is necessary either for the activation, growth, or differentiation of the regulatory cell population or alternatively, to render the cytotoxic population responsive to the activity of regulatory cells. Gel filtration studies indicate that the molecular weight of this factor is between 60 and 80 kd. This factor appears to be distinct from known immunologically active cytokines. It is conceivable that deficiencies of this cytokine may be relevant to the pathogenesis of autoimmune diseases or graft-versus-host reactions.
Department of Immunology and Cell Biology, Sloan-Kettering Institute for Cancer Research, New York, NY 10021.
K
K
Rosenkrantz
K
K
Bhimani
K
K
Welte
J
J
Buck
J
J
DiSanto
E
E
Levi
J
J
DiMartino
U
U
Hammerling
B
B
Dupont
N
N
Flomenberg
D001685:Biological Factors / Q000302:isolation & purification / Q000502:physiology*; D002478:Cells, Cultured; D002850:Chromatography, Gel; D016207:Cytokines; D003602:Cytotoxicity, Immunologic / Q000502:physiology*; D006801:Humans; D007376:Interleukin-2 / Q000494:pharmacology; D008970:Molecular Weight; D011994:Recombinant Proteins; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D001685:Biological Factors; D016207:Cytokines; D007376:Interleukin-2; D011994:Recombinant Proteins; D013755:Tetradecanoylphorbol Acetate